Skip to main content

Eminent Cancer Researcher Dies

Indiana University’s David Flockhart, a pioneer of personalized medicine, has passed away at age 63. 

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

INDIANA UNIVERSITY David Flockhart, a cancer researcher who founded one of the first institutes for personalized medicine in the U.S., died of glioblastoma multiforme—an advanced form of brain cancer—late last month (November 26). He was 63 years old.

Flockhart, a native of Edinburgh, Scotland, pioneered the field of pharmacogenomics, elucidating the role of CYP2D6, an enzyme that converts breast cancer drug tamoxifen into endoxifen, a metabolite that helps prevent relapse. His lab found that natural variants in the gene that encodes CYP2D6 can disrupt the pathway, making tamoxifen less effective in women who carry them.

“Dave Flockhart was a unique individual in many ways, combining outstanding scientific skills with integrity and compassion,” William Dalton, board chair at the Personalized Medicine Coalition (PMC), said in a statement. “He will be remembered as an impactful scientist, clinician and mentor dedicated to the advancement of personalized medicine to improve the lives of patients everywhere. Indeed, Dave was truly inspirational in his ability to learn and ultimately ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation